Maravai LifeSciences Holdings, Inc. reported earnings results for the fourth quarter and full year ended December 31, 2023. For the fourth quarter, the company reported sales was USD 74.14 million compared to USD 204.71 million a year ago. Net loss was USD 105.96 million compared to net income of USD 37.63 million a year ago. Basic loss per share from continuing operations was USD 0.8 compared to basic earnings per share from continuing operations of USD 0.28 a year ago. Diluted loss per share from continuing operations was USD 0.8 compared to diluted earnings per share from continuing operations of USD 0.28 a year ago.
For the full year, sales was USD 288.95 million compared to USD 883 million a year ago. Net loss was USD 119.03 million compared to net income of USD 220.21 million a year ago. Basic loss per share from continuing operations was USD 0.9 compared to basic earnings per share from continuing operations of USD 1.67 a year ago. Diluted loss per share from continuing operations was USD 0.9 compared to diluted earnings per share from continuing operations of USD 1.67 a year ago.